{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:30:58Z","timestamp":1784259058309,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jceh.2022.10.010","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T12:54:54Z","timestamp":1667480094000},"page":"479-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Determining Prognosis of ALD and Alcohol-associated Hepatitis"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-3157","authenticated-orcid":false,"given":"Heer","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4246-6998","authenticated-orcid":false,"given":"Winston","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.10.010_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cld.164","article-title":"Alcoholic hepatitis: diagnosis and prognosis","volume":"2","author":"Drinane","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.10.010_bib2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/MCG.0b013e3181fdef1d","article-title":"Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States","volume":"45","author":"Liangpunsakul","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.10.010_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4254\/wjh.v3.i8.205","article-title":"Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: current status","volume":"3","author":"Singal","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40364-015-0046-z","article-title":"Prognostic models for alcoholic hepatitis","volume":"3","author":"Rahimi","year":"2015","journal-title":"Biomark Res"},{"key":"10.1016\/j.jceh.2022.10.010_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.10.010_bib6","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.3748\/wjg.v12.i43.6909","article-title":"Current concepts and controversies in the treatment of alcoholic hepatitis","volume":"12","author":"Rongey","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.10.010_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.14309\/ajg.0000000000001596","article-title":"The MELD score is superior to the Maddrey discriminant function score to predict short-term mortality in alcohol-associated hepatitis: a global study","volume":"117","author":"Morales-Arr\u00e1ez","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.10.010_bib8","first-page":"1089","article-title":"Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis","volume":"60","author":"Monsanto","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jceh.2022.10.010_bib9","first-page":"57","article-title":"[MELD or Maddrey?: comparison of two prognosis models in patients with alcohol toxic hepatitis]","volume":"73","author":"Zapata-Irris\u00f3n","year":"2008","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.jceh.2022.10.010_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jgh.12400","article-title":"Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis","volume":"29","author":"Kadian","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.10.010_bib12","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival","volume":"66","author":"Altamirano","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.10.010_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000503921","article-title":"Child-Turcotte-Pugh score, MELD score and MELD-Na score as predictors of short-term mortality among patients with end-stage liver disease in Northern India","volume":"5","author":"Acharya","year":"2020","journal-title":"Inflamm Intest Dis"},{"key":"10.1016\/j.jceh.2022.10.010_bib14","doi-asserted-by":"crossref","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","article-title":"Child\u2013Pugh versus MELD score for the assessment of prognosis in liver cirrhosis","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jceh.2022.10.010_bib15","first-page":"675","article-title":"Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit","volume":"47","author":"Dupont","year":"2015","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jceh.2022.10.010_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.10.010_bib17","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3748\/wjg.v21.i11.3197","article-title":"Hyponatremia in cirrhosis: pathophysiology and management","volume":"21","author":"John","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.10.010_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ajt.16142","article-title":"Validation of the model for end-stage liver disease sodium (MELD-Na) score in the Eurotransplant region","volume":"21","author":"Goudsmit","year":"2021","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.jceh.2022.10.010_bib19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.10.010_bib20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.10.010_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4065\/mcp.2010.0281","article-title":"Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis","volume":"86","author":"Vaa","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jceh.2022.10.010_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/alcalc\/35.6.612","article-title":"Mechanisms of hyponatraemia in alcohol patients","volume":"35","author":"Liamis","year":"2000","journal-title":"Alcohol Alcohol Oxf Oxfs"},{"key":"10.1016\/j.jceh.2022.10.010_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.10.010_bib24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.10.010_bib25","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.10.010_bib26","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.10.010_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.23736\/S0026-4806.17.05136-9","article-title":"A\u00a0prognostic evaluation and management of alcoholic hepatitis","volume":"108","author":"Rana","year":"2017","journal-title":"Minerva Med"},{"key":"10.1016\/j.jceh.2022.10.010_bib29","first-page":"2338","article-title":"Day-4 Lille score is a good prognostic factor and early predictor in assessing therapy response in patients with liver cirrhosis and severe alcoholic hepatitis","volume":"10","author":"Foncea","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jceh.2022.10.010_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.10.010_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1745-6215-14-262","article-title":"Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial","volume":"14","author":"Forrest","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.jceh.2022.10.010_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.gastro.2015.06.020","article-title":"MELDing the Lille score to more accurately predict mortality in alcoholic hepatitis","volume":"149","author":"Kamath","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.10.010_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cld.2021.03.003","article-title":"Diagnosis of alcohol-associated hepatitis: when is liver biopsy required?","volume":"25","author":"Arab","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.10.010_bib34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cgh.2013.08.048","article-title":"The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis","volume":"12","author":"Hanouneh","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2013.10.032","article-title":"The liver breath! Breath volatile organic compounds for the diagnosis of liver disease","volume":"12","author":"Khalid","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.hep.2003.09.038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.10.010_bib37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1177\/2050640620957140","article-title":"Refining criteria for liver biopsy in severe alcoholic hepatitis: moving the field forward","volume":"8","author":"Palmer","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jceh.2022.10.010_bib38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/apt.16173","article-title":"Editorial: liver biopsy in alcoholic hepatitis-more\u00a0clarity on when it may be needed","volume":"53","author":"Haiar","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.10.010_bib39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/apt.16157","article-title":"The diagnostic and prognostic significance of liver histology in alcoholic hepatitis","volume":"53","author":"Forrest","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.10.010_bib40","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2011.02.021","article-title":"The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis","volume":"55","author":"Mookerjee","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jceh.2021.08.009","article-title":"Liver biopsy in patients with alcohol-associated liver disease with acute-on-chronic liver failure","volume":"12","author":"Jophlin","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib42","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.14309\/ajg.0000000000001750","article-title":"Lung infection affects access to treatment and short-term outcome in patients with severe alcohol-related hepatitis treated with corticosteroids","volume":"117","author":"Ntandja Wandji","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.10.010_bib43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cld.2016.02.007","article-title":"Prognosis and prognostic scoring models for alcoholic liver disease and acute alcoholic hepatitis","volume":"20","author":"Gholam","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.10.010_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1155\/2015\/814827","article-title":"Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: a population-based study","volume":"29","author":"Pang","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib45","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s10620-013-3020-3","article-title":"Predicting short-term mortality and long-term survival for hospitalized US patients with alcoholic hepatitis","volume":"59","author":"Cuthbert","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.10.010_bib46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/MEG.0000000000000926","article-title":"Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis","volume":"29","author":"Fernandes","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib47","first-page":"511","article-title":"Predicting long-term prognosis in severe alcoholic hepatitis","volume":"40","author":"Stickel","year":"2020","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jceh.2022.10.010_bib48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.12427","article-title":"Determinants of long-term outcome in severe alcoholic hepatitis","volume":"38","author":"Potts","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.10.010_bib49","first-page":"721","article-title":"Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials","volume":"36","author":"Hmoud","year":"2016","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jceh.2022.10.010_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cld.2021.03.004","article-title":"Assessing the severity and prognosis of alcoholic hepatitis","volume":"25","author":"Mitra","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.10.010_bib51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jgh.13084","article-title":"Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism","volume":"31","author":"Kim","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.10.010_bib52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13054-018-2156-0","article-title":"Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure","volume":"22","author":"Engelmann","year":"2018","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.jceh.2022.10.010_bib53","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mayocp.2021.10.026","article-title":"The mortality index for alcohol-associated hepatitis: a novel prognostic score","volume":"97","author":"Kezer","year":"2022","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322005084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322005084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:09:43Z","timestamp":1760854183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322005084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0973688322005084"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.10.010","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining Prognosis of ALD and Alcohol-associated Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}